Scientists have identified a protein that plays a pivotal role in the action of several emerging cancer therapies. The researchers say the discovery will likely aid efforts to fine-tune the use of immunotherapies against several challenging cancers. They report their findings in the journal Cancer Research. The paper is titled, "Plasma membrane channel TRPM4 mediates immunogenic therapy-induced necrosis."
from Medical Xpress - latest medical and health news stories https://ift.tt/c7AuNmr
